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Abstract. The chemistry of three prototypes of secondary alkynylcarbinols (ACs), recently 
highlighted as challenging targets in anti-tumoral medicinal chemistry, is further documented by 
results on n-alkyl, alkynyl and alkenyl representatives. The N-naphthyl carbamate of an n-butyl-AC 
is thus characterized by X-ray crystallography. A novel dialkynylcarbinol (DAC) with synthetic 
potential is described, namely the highly dissymmetrical triisopropylsilyl-protected version of 
diethynylmethanol. The latter is shown to act as a dipolarophile in a selective Huisgen reaction with 
benzyl azide under CuAAC click conditions, giving an alkenyl-AC, where the alkene unsaturation 
is embedded in a 1,4-disubstituted 1,2,3-triazole ring, as confirmed by X-ray crystallography.  
________________________________________________________________________________ 
Introduction 
Bio-inspired asymmetric secondary 
terminal alkynylcarbinols (ACs) substituted by 
various -unsaturated units have been recently 
highlighted as relevant pharmacophores [1,2]. 
Natural lipidic alkenyl-ACs (AACs) extracted 
from marine sponges had indeed long been 
reported to exhibit significant in vitro anti-
tumoral cytotoxicity [3]. Beyond total synthesis 
achievements [2,4], a systematic four-parameter 
variation study, then refined to a three-
parameter one, was undertaken from the (S)-
eicos-(4E)-en-1-yn-3-ol model extracted from 
Cribrochalina vasculum (Figure 1)[5].  
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=> three-parameter pharmacophore study:
 
Figure 1. Natural anti-tumoral AAC (top), model for a 
systematic three-parameter pharmacophore study (bottom) 
 
Derived structure-activity relationships 
indicate significant chirality effects, the 
eutomers being the unnatural enantiomers, with 
IC50 values ca one order of magnitude higher 
than those of the natural distomers [1]. 
Moreover, artificial lipidic alkynyl-ACs, i.e. 
dialkynyl-carbinols (DACs), proved to be the 
most potent pharmacophores, with anti-tumoral 
cytotoxicity IC50 values down to 60 nM on 
HCT116 cell lines [1].  
Further exploration of the chemical 
space by variation of the pharmacophore 
structure relies first on the availability of 
chemical data and synthesis tools. This is 
hereafter addressed through variations of the 
AC substituent according to the hybridization 
state of the first carbon atom, which can be 
either sp
3
, sp
2
, or sp.  
 
Results and discussion 
The disclosed insights into the chemistry 
of novel terminal AC prototypes are presented 
in the order: n-alkyl-ACs (sp
3
), alkynyl-ACs 
(DACs, sp), and alkenyl-ACs (AACs, sp
2
). 
 
1. n-Alkyl-ACs: the “short” n-butyl derivative 
and a carbamate thereof 
The known n-butyl-AC 1 can be 
obtained by reaction of trimethylsilyl-
propiolaldehyde [6] with n-BuLi or n-BuMgBr 
[7]. In view of possible analysis of scalemic 
samples by chiral HPLC [1], the racemic n-
butyl-AC 1 was reacted with naphth-1-yl 
isocyanate to give the corresponding carbamate 
2 in 50 % yield. 
O
H
NCO
DBU (1%)
DCM, r.t., 15 h
~ 50 %
1) n-BuLi, THF
-78oC -> r. t.
17 h
TMS
crystals
1)
2) crystalization
from oil
O O
NH
1 2
TMS
n-Bu
OH
TMS
n-Bu
2) H+
 
Scheme 1. Preparation of the N-naphthyl carbamate of the 
known n-butyl-AC 1 (see Figure 2). TMS = SiMe3. 
 
 The isolated oil slowly gave crystals of 
2 suitable for X-ray diffraction (XRD) analysis 
revealing rather classical geometrical features. 
A cisoid conformation of the (naphthtyl)N–
C(O) bond of the carbamate unit, along with a 
quite acute O–C(O)–N bond angle, are however 
noticeable (Figure 2, Table 1). A quite large 
dihedral angle between the naphthyl and 
carbamate planes of 53.7° also indicates a weak 
conjugation between the two π systems. 
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Figure 2. Molecular view of the X-ray crystal structure of 
the carbamate 2 (Scheme 1). For clarity, hydrogen atoms 
and disordered atoms are omitted  (see Table 1 and 
CCDC n° 1038852). Selected bond lengths (Å) and bond 
angles (°) (disordered C18 atom): C12-O2 = 1.461(2), 
C12-C17 = 1.468(3), C13-C12 = 1.510(3), C17-C18'= 
1.193(7) and C17-C18 = 1.224(6), C11-O1                    
1.214(3), C11-N1 = 1.342(3), O2-C12-C17 = 105.19(17), 
O2-C12-C13 = 110.37(18), C17-C12-C13 = 113.0(2), 
C12-C17-C18 = 171.3(4) and C12-C17-C18’ = 171.6(4), 
N1-C11-O2 = 109.54(18). 
 
2. Alkynyl-ACs: triisopropylsilylpenta-1,4-diyn-
3-ol, a highly dissymmetrical equivalent of 
diethynylmethanol 
The pharmacophoric value of lipidic 
DACs [1] calls for systematic efforts toward the 
investigation of their synthesis and reactivity. 
The chemistry of DACs, mostly tertiary, is 
largely documented for their use as basic 
synthons in the synthesis of hexaoxy-
[6]pericyclynes serving as direct precursors of 
carbo-benzenes [8,9] or related acetylenic 
chromophores [10]. In the secondary DAC 
series, trimethylsilyl-penta-1,4-diyn-3-ol 3a is a 
currently referenced dissymmetrical equivalent 
of diethynylmethanol (Scheme 2) [9,11]. To the 
best of the authors’ knowledge, the more 
dissymmetrical and more robust 
triisopropylsilyl homologue 3b has not been 
described hitherto. The latter has however been 
readily obtained as an oil in 70 % isolated yield 
by a Grignard reaction of ethynylmagnesium 
bromide with triisopropylsilylpropiolaldehyde 
(Scheme 2). In view determining structural 
features of the bulky DAC 3b by derivatization 
to a crystalline solid, the 3,3-dinitrobenzoate 
ester 4 was targeted. The latter was obtained in 
80 % yield by reaction of 3b with meta-
dinitrobenzoic acid (Scheme 2). The ester 4 was 
however isolated as a foam, from which 
sufficiently large single crystals could not be 
obtained, thus preventing structural 
determination by XRD analysis. 
 
TIPS
OH
TIPS
H
O
70 %
DCC, DMAP O
NO2O2N
80 %3b
H
TIPS
O
H
DCM, r. t. 
18 h
4
m-DNBA
TMS
OH
H3a
current 
dissymmetrical equivalent 
of diethynylmethanol:
1) HC2MgBr
Et2O, 0
oC
6 h
2) H+
 
Scheme 2. Preparation of the disymmetrical equivalent of 
diethynylmethanol 3b and m-dinitrobenzoate ester 
thereof. TIPS = Si
i
Pr3; m-DNBA = m-dinitrobenzoic acid; 
DCC = dicyclohexylcarbodiimide; DMAP = 4-
dimethylaminopyridine . 
 
3. Alkenyl-ACs: a 1,2,3-triazolyl-carbinol 
The reactivity of the above-disclosed 
dissymmetrical equivalent of diethynylmethanol 
was investigated in a Cu-catalyzed Huisgen 
alkyne-azide cycloaddition (CuAAC). With 
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benzyl azide, standard click conditions (CuSO4 
and ascorbic acid [12]) afforded the triazolyl-
AC 5 with complete 1,4-stereoselectivity 
(Scheme 3), as previously observed from other 
dialkynylcarbinol dipolarophiles [13,14]. 
 
N3
TIPS
OH
N
N
N
Ph70 %
DMF/H2O, r. t. 
6 h
CuAAC
(CuSO4, 
ascorbic acid)
TIPS
OH
3b
H
5  
Scheme 3. Huisgen reaction of the DAC 3b with benzyl 
azide under click conditions giving the 1,2,3-triazolyl-
alkynylcarbinol 5 as a particular alkenyl-AC (Figure 3).  
 
The triazolyl-AC 5 actually corresponds 
to a particular type of AAC, where the 
diaminoalkene unsaturation, embedded in a 
1,2,3-triazole ring, is trans-substituted with 
respect to the carbinol center [15].  
 
Figure 3. Molecular view of the X-ray crystal structure of 
the triazolyl-AC 5 (Scheme 3). For clarity, hydrogen 
atoms (except for that on O1) and disordered atoms are 
omitted (see Table 1 and CCDC no 1038853). Selected 
bond lengths (Å) and bond angles (°): C2-C3 = 1.194(7), 
C1-O1 = 1.425(7), C1-C2 = 1.486(7), C1-C13 = 
1.464(12), C13-C14 = 1.381(16), O1-C1-C2 = 109.2(5), 
O1-C1-C13 = 115(2), C2-C1-C13 = 108.2(12), C1-C2-C3 
= 176.2(6), C1-C13-C14 = 127.0(17). 
The 1,4-disubstitution pattern has been 
confirmed by XRD analysis of a single crystal 
of 5 (Figure 3, Table 1). It can also be noted 
that the C-C(OH)-C carbinol angle is more 
acute in 5 than in the n-butyl-AC carbamate 2 
(ca 108° vs ca 113°), and that the mean plane of 
the (disordered) triazole ring is almost 
perpendicular to the C(triazole)–C–OH plane 
(dihedral angle of ca 87°). 
 
Conclusions 
The disclosed results provide  
complementary information on the chemistry of 
the sp
3
, sp and sp
2
 series of C-substituted 
secondary terminal ACs. Although quite 
standard in terms of chemical structure, the 
triisopropylsilyl-penta-1,4-diyn-3-ol DAC 3b, 
described here for the first time, is a more 
dissymmetrical and more robust equivalent of 
diethynylmethanol than the classical 
trimethylsilyl homologue 3a: 3b can therefore 
be considered as a potential key synthon for the 
versatile preparation of generic ACs with 
improved selectivity with respect to 3a. 
  
Experimental section. 
General.  
 The following solvents were dried and distilled 
prior to use: THF and diethyl ether (Et2O) over 
sodium/benzophenone, dichloromethane (DCM) 
over CaH2. All other solvents, like petroleum 
ether (PE), and reagents were used as 
commercially available. 3-(Trimethylsilyl)- and 
3-(triisopropylsilyl)-propiolaldehydes were 
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prepared using known procedures [6]. 1-
(Trimethylsilyl)hept-1-yn-3-ol 1 was prepared 
by reaction of trimethylsilyl-propiolaldehyde 
with n-BuLi (instead of n-BuMgBr)[7]. 
Analytical thin-layer chromatography (TLC) 
was performed with Merck silica gel 60 F254 pre-
coated plates. Chromatograms were observed 
under UV light and/or visualized by heating 
plates dipped in 10 % phosphomolybdic acid in 
EtOH, or in a KMnO4 aqueous solution (for the 
triazole 5). Column chromatography was carried 
out with SDS 35-70 mm flash silica gel. NMR 
spectra were recorded in CDCl3 solutions on a 
Bruker Advance 300 instrument. 
1
H and 
13
C 
chemical shifts () are given in ppm with 
positive values to high frequency relative to the 
tetramethylsilane resonances determined from 
the residual solvent peaks. Coupling constants J 
are given in Hertz. Mass spectrometry (MS) was 
performed on a ThermoQuest TSQ 7000 
instrument, and high-resolution MS (HRMS) on 
a Thermo-Finnigan MAT 95 XL instrument. IR 
analyses were run on a Thermo-Nicolet 
Diamond ATR (4 cm
–1 
of resolution, 16 scans) 
equipped with a DTGS detector. 
 
Experimental procedures and characterizations. 
1-(Trimethylsilyl)hept-1-yn-3-yl-N-
(naphthalen-1-yl) carbamate (2). Naphth-1-yl 
isocyanate (152 mg, 0.9 mmol, 1.5 equiv.) and 
DBU (9 mg, 0.06 mmol, 0.1 equiv.) in DCM 
were added to a solution of trimethylsilylhept-1-
yn-3-ol 1 (110 mg, 0.6 mmol, 1 equiv.) in DCM 
(0.5 mL). After stirring overnight, water was 
added and the mixture extracted with DCM. 
After standard treatment of the combined 
organic layers, the crude product was  purified 
by chromatography over silica gel (pentane/ 
Et2O = 8/2) to give the carbamate 2 as a viscous 
oil (158 mg, 50 %), which crystallized with time.  
 
1-[Tris(propan-2-yl)silyl]penta-1,4-diyn-3-ol 
(3b). Ehynylmagnesium bromide (1 mL, 0.5 M 
in THF, 0.52 mmol, 1.1 equiv.) was added to a 
solution of 3-[tris(propan-2-yl)silyl]prop-2-ynal 
(100 mg, 0.47 mmol) in THF (10 mL) at 0
°
C, 
and the reaction mixture was stirred for 6 h at 
0°C. After addition of saturated aqueous NH4Cl, 
the mixture was partitioned with brine and Et2O 
and the aqueous phase extracted with Et2O. 
After standard treatment of the combined 
organic layers, chromatography of the crude 
product though silica gel (pentane/Et2O = 15/1) 
gave 3b as a colorless oil (78 mg, 70 %).  
1
H NMR (300 MHz): δ = 1.09 (s, 21H), 2.55 (s, 
1H), 2.56 (s, 1H), 5.14 (s, 1H); 
13
C NMR (75 
MHz): δ = 11.2, 18.6, 52.5, 72.6, 81.1, 86.5, 
103.6; IR (neat): ν = 3312, 2943, 2892, 2866, 
2177, 2125, 1463, 1384, 1367, 1289, 1044, 
1017, 997, 919, 881, 672, 657, 591, 562, 504 
cm
-1
; MS (DCI, NH3): m/z (%): 254.2 (90) 
[M+NH4]
+
, 236.2 (10) [M]
+
. 
 
1-[Tris(propan-2-yl)silyl]penta-1,4-diyn-3-yl 
3,5-dinitrobenzoate (4). To a solution of 1-
[tris(propan-2-yl)silyl]penta-1,4-diyn-3-ol 3b 
(100 mg, 0.42 mmol) in DCM (10 mL) were 
added successively: DCC (105 mg, 0.51 mmol, 
FRENCH-UKRAINIAN JOURNAL OF CHEMISTRY (2015, VOLUME 3, ISSUE 1)  
26 
 
1.1 equiv.), DMAP (17 mg, 0.14 mmol, 0.3 
equiv.) and m-DNBA (108 mg, 0.51 mmol, 1.1 
equiv.). After stirring at r.t. for 18 h, the mixture 
was poured into saturated aqueous NaHCO3 (10 
mL) and extracted with DCM (2 x10 mL). The 
organic layer was washed with water (10 mL) 
and brine (10 mL), dried (Na2SO4) and 
concentrated under reduced pressure. Flash 
chromatography of the residue over silica gel 
(Rf = 0.4, pentane/ Et2O = 10/1), gave ester 4 as 
a colorless foam (145 mg, 80 %).  
1
H NMR (400 MHz): δ = 1.08 (s, 21H), 2.69 (d, 
J = 4 Hz, 1H), 6.34 (d, J = 4 Hz, 1H), 9.20 (m, 
3H), 9.26 (m, 2H); 
13
C NMR (101 MHz): δ = 
11.2, 18.6, 55.9, 75.1, 76.6, 90.4, 98.4, 123.0, 
129.9, 133.1, 148.9, 161.0; IR (neat): ν = 3395, 
3297, 3288, 3103, 2944, 2892, 2866, 2252, 
2229, 2139, 2074, 1745, 1629, 1598, 1547, 
1461, 1385, 1344, 1328, 1316, 1294, 1260, 
1155, 1073, 1018, 978, 921, 883, 857, 820, 796, 
769, 729, 721, 681, 645, 624, 607, 583, 562 cm
-
1
; MS (DCI, NH3): m/z (%): 430.2 (100) [M]
+
, 
210.9 (100), 181.0 (5). 
 
1-(1-Benzyl-1H-1,2,3-triazol-4-yl)-3-
[tris(propan-2-yl)silyl]prop-2-yn-1-ol (5).  To 
a solution of 1-[tris(propan-2-yl)silyl]penta-1,4-
diyn-3-ol 3b (100 mg, 0.42 mmol, 1 equiv.) and 
benzyl azide (56 mg, 0.42 mmol, 1 equiv.) in 
DMF (8 mL) were added CuSO4•5H2O (0.1 g), 
ascorbic acid (0.1 g), and H2O (1 mL). The 
mixture was then stirred at r.t. until the terminal 
alkyne has disappeared (TLC monitoring, over 
nearly 6 h). Saturated aqueous NH4Cl (10 mL) 
and Et2O (10 mL) were added, and the organic 
phase was separated, washed with brine (2 x10 
mL), and dried over MgSO4. Purification by 
column chromatography (Rf  = 0.5, Et2O/pentane 
= 2/1) afforded the 1,2,3-triazolylcarbinol 5 as a 
white solid (108 mg, 70 %). 
1
H NMR (400 MHz): δ = 1.03 (s, 21H), 2.76 (d, 
J = 4 Hz, 1H), 5.52 (s, 2H), 5.68 (d, J = 4 Hz, 
1H), 7.27 (m, 2H), 7.37 (m, 3H), 7.49 (s, 1H); 
13
C NMR (101 MHz): δ = 11.1, 18.5, 29.7, 54.4, 
57.5, 88.1, 107.2, 121.4, 128.3, 128.9, 129.2, 
134.1; IR (neat): ν = 3290, 3067, 3034, 2942, 
2892, 2865, 2176, 1704, 1545, 1497, 1462, 
1383, 1366, 1280, 1226, 1160, 1122, 1045, 996, 
976, 919, 883, 822, 800, 769, 723, 678, 601, 
592, 577, 532 cm
-1
; MS (DCI, NH3): m/z (%): 
370.1 (100) [MH]
+
, 367.8 (5), 326.1 (5), 188.0 
(1), 108.0. 
 
Crystallography. 
X-ray intensity data of crystals of 2 and 5 were 
collected were collected at 193(2) K on a 
Bruker-AXS APEX II QUAZAR diffractometer 
equipped with a 30W air-cooled microfocus 
source, using MoKα radiation ( = 0.71073Å). 
The data were integrated with SAINT, and an 
empirical absorption correction with SADABS 
was applied [16].
 
The structures were solved by 
direct methods (SHELXS-97) and refined using 
the least-squares method on F
2
 [17]. All non-H 
atoms were refined with anisotropic 
displacement parameters. The H atoms were 
refined isotropically at calculated positions 
using a riding model. The hydroxyl H atom of 5 
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was located in difference Fourier maps and 
included in the subsequent refinement without 
using restraints. Data are listed in Table 1. 
CCDC-1038852 (2) and CCDC-1038853 (5) 
contain the supplementary crystallographic data, 
which can be obtained free of charge from the 
Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
 
 
Table 1. Crystallographic data and structural refinement 
parameters for 2 and 5. 
 2 5 
Chemical formula C21H27NO2Si C21H31N3OSi 
Mr 353.53 369.58 
Crystal system monoclinic triclinic 
Space group P 21/c P1 
a [Å] 7.7295(6) 8.043(2) 
b [Å] 30.407(2) 11.428(3) 
c [Å] 9.0824(7) 12.777(3) 
α [°] 90 96.854(13) 
β [°] 95.688(4) 101.838(10) 
γ [°] 90 103.855(12) 
V [Å3] 2124.1(3) 1098.3(5) 
Z 4 2 
Reflections collected 28188 14592 
Independent 
reflections 
4072 [R(int) = 
0.0403] 
3556 [R(int) = 
0.1855] 
ρcalc [g cm
-3
] 1.105 1.118 
μ (MoKα) [mm
-1
] 0.123 0.121 
Crystal size (mm
3
) 
0.22 x 0.18  
x 0.02 
0.24 x 0.04  
x 0.02 
GOF on F² 1.068 0.964 
R (I > 2σ(I)) 0.0548 0.0851 
wR² (all data) 0.1671 0.2446 
Largest difference 
peak and hole [eÅ-3] 
0.374 and 
-0.510 
0.204 and 
-0.219 
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